MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/akt-induced transformation

Molecular and Cellular Biology

Volumn 33, Issue 22, 2013, Pages 4473-4491

  Di Giorgio, Eros ^a   Clocchiatti, Andrea ^a   Piccinin, Sara ^b   Sgorbissa, Andrea ^a   Viviani, Giulia ^a   Peruzzo, Paolo ^a   Romeo, Salvatore ^c   Rossi, Sabrina ^c   Tos, Angelo Paolo Dei ^c   Maestro, Roberta ^b   Brancolini, Claudio ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c Treviso General Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 7; KRUPPEL LIKE FACTOR 2; MYOCYTE ENHANCER FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TUBERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SOFT TISSUE SARCOMA;

ANIMALS; CARCINOGENESIS; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, INBRED BALB C; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-AKT; REPRESSOR PROTEINS; SARCOMA; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84886996928     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01050-13     Document Type: Article

References (48)

1. Martin M, Kettmann R, Dequiedt F. 2007. Class IIa histone deacetylases: regulating the regulators. Oncogene 26:5450-5467.
2. Haberland M, Montgomery RL, Olson EN. 2009. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10:32-42.
3. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, Verdin E. 2002. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/NCoR. Mol. Cell 9:45-57.
4. Lahm A, Paolini C, Pallaoro M, Nardi MC, Jones P, Neddermann P, Sambucini S, Bottomley MJ, Lo Surdo P, Carfí A, Koch U, De Francesco R, Steinkühler C, Gallinari P. 2007. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 104:17335-17340.
5. Yang XJ, Seto E. 2008. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell. Biol. 9:206-218.
6. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38: 228-233.
7. Liu F, Pore N, Kim M, Voong KR, Dowling M, Maity A, Kao GD. 2006. Regulation of histone deacetylase 4 expression by the SP family of transcription factors. Mol. Biol. Cell 17:585-597.
8. Paroni G, Fontanini A, Cernotta N, Foti C, Gupta MP, Yang XJ, Fasino D, Brancolini C. 2007. Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4. Mol. Cell. Biol. 27: 6718-6732.
9. Cernotta N, Clocchiatti A, Florean C, Brancolini C. 2011. Ubiquitindependent degradation of HDAC4, a new regulator of random cell motility. Mol. Biol. Cell 22:278-289.
10. Backs J, Worst BC, Lehmann LH, Patrick DM, Jebessa Z, Kreusser MM, Sun Q, Chen L, Heft C, Katus HA, Olson EN. 2011. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell Biol. 195:403-4015.
11. Clocchiatti A, Florean C, Brancolini C. 2011. Class IIa HDACs: from important roles in differentiation to possible implications in tumorigenesis. J. Cell. Mol. Med. 15:1833-1846.
12. Grozinger CM, Schreiber SL. 2000. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. U. S. A. 97:7835-7840.
13. Wang AH, Kruhlak MJ, Wu J, Bertos NR, Vezmar M, Posner BI, Bazett-Jones DP, Yang XJ. Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol. 20:6904-6912.
14. Martin M, Potente M, Janssens V, Vertommen D, Twizere JC, Rider MH, Goris J, Dimmeler S, Kettmann R, Dequiedt F. 2008. Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 105:4727-4732.
15. Paroni G, Cernotta N, Dello Russo C, Gallinari P, Pallaoro M, Foti C, Talamo F, Orsatti L, Steinkühler C, Brancolini C. 2008. PP2A regulates HDAC4 nuclear import. Mol. Biol. Cell 19:655-667.
16. Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099-50107.
17. Jayathilaka N, Han A, Gaffney KJ, Dey R, Jarusiewicz JA, Noridomi K, Philips MA, Lei X, He J, Ye J, Gao T, Petasis NA, Chen L. 2012. Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2. Nucleic Acids Res. 40:5378-5388.
18. Clocchiatti A, Di Giorgio E, Demarchi F, Brancolini C. 2013. Beside the MEF2 axis: unconventional functions of HDAC4. Cell Signal 25:269-276.
19. Potthoff MJ, Olson EN. 2007. MEF2: a central regulator of diverse developmental programs. Development 134:4131-4140.
20. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
21. Schwieger M, Schüler A, Forster M, Engelmann A, Arnold MA, Delwel R, Valk PJ, Löhler J, Slany RK, Olson EN, Stocking C. 2009. Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C. Blood 114:2476-2488.
22. Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P, Deubzer HE, Lodrini M, Taylor MD, von Deimling A, Pfister S, Witt O. 2010. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin. Cancer Res. 16:3240-3252.
23. Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M, Vuerhard M, Buijs-Gladdines J, Kooi C, Klous P, van Vlierberghe P, Ferrando AA, Cayuela JM, Verhaaf B, Beverloo HB, Horstmann M, de Haas V, Wiekmeijer AS, Pike-Overzet K, Staal FJ, de Laat W, Soulier J, Sigaux F, Meijerink JP. 2011. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 19:484-497.
24. + breast tumors. FASEB J. 27:942-954.
25. Mottet D, Pirotte S, Lamour V, Hagedorn M, Javerzat S, Bikfalvi A, Bellahcène A, Verdin E, Castronovo V. 2009. HDAC4 represses p21WAF1/ Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 28:243-256.
26. Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH, Mariadason JM. 2008. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol. Biol. Cell 19:4062-4075.
27. Cadot B, Brunetti M, Coppari S, Fedeli S, de Rinaldis E, Dello Russo C, Gallinari P, De Francesco R, Steinkühler C, Filocamo G. 2009. Loss of histone deacetylase 4 causes segregation defects during mitosis of p53-deficient human tumor cells. Cancer Res. 69:6074-6082.
28. Todaro GJ, Green H. 1963. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17:299-313.
29. Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C, Brancolini C. 2004. Caspase-dependent regulation of histone deacetylase 4 nuclearcytoplasmic shuttling promotes apoptosis. Mol. Biol. Cell 15:2804-2818.
30. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:15545-15550.
31. Nurtdinov RN, Vasiliev MO, Ershova AS, Lossev IS, Karyagina AS. 2010. PLANdbAffy: probe-level annotation database for Affymetrix expression microarrays. Nucleic Acids Res. 38:D726-D730.
32. Dequiedt F, Kasler H, Fischle W, Kiermer V, Weinstein M, Herndier BG, Verdin E. 2003. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity. 18:687-698.
33. Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S, Plaisier S, Garraway IP, Huang J, Graeber TG, Wu H. 2011. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell 19:792-804.
34. Peña-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TA, Zou L, Xie XJ, Corey DR, Brugarolas J. 2011. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 30:3242-3258.
35. Bromann PA, Korkaya H, Webb CP, Miller J, Calvin TL, Courtneidge SA. 2005. Platelet-derived growth factor stimulates Src-dependent mRNA stabilization of specific early genes in fibroblasts. J. Biol. Chem. 280: 10253-10263.
36. Molkentin JD, Black BL, Martin JF, Olson EN. 1996. Mutational analysis of theDNAbinding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell. Biol. 16:2627-2636.
37. Rosenbloom KR, Dreszer TR, Pheasant M, Barber GP, Meyer LR, Pohl A, Raney BJ, Wang T, Hinrichs AS, Zweig AS, Fujita PA, Learned K, Rhead B, Smith KE, Kuhn RM, Karolchik D, Haussler D, Kent WJ. 2010. ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Res. 38:D620-D625.
38. Grégoire S, Tremblay AM, Xiao L, Yang Q, Ma K, Nie J, Mao Z, Wu Z, Giguère V, Yang XJ. 2006. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281:4423- 4433.
39. Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME. 2006. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311:1008-10012.
40. Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, Decarolis PL, Shah K, Socci ND, Weir BA, Ho A, Chiang DY, Reva B, Mermel CH, Getz G, Antipin Y, Beroukhim R, Major JE, Hatton C, Nicoletti R, Hanna M, Sharpe T, Fennell TJ, Cibulskis K, Onofrio RC, Saito T, Shukla N, Lau C, Nelander S, Silver SJ, Sougnez C, Viale A, Winckler W, Maki RG, Garraway LA, Lash A, Greulich H, Root DE, Sellers WR, Schwartz GK, Antonescu CR, Lander ES, Varmus HE, Ladanyi M, Sander C, Meyerson M, Singer S. 2010. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat. Genet. 42:715-721.
41. Gibault L, Ferreira C, Pérot G, Audebourg A, Chibon F, Bonnin S, Lagarde P, Vacher-Lavenu MC, Terrier P, Coindre JM, Aurias A. 2012. From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas. Mod. Pathol. 25:197-211.
42. Piccinin S, Tonin E, Sessa S, Demontis S, Rossi S, Pecciarini L, Zanatta L, Pivetta F, Grizzo A, Sonego M, Rosano C, Dei Tos AP, Doglioni C, Maestro R. 2012. A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. Cancer Cell 22:404-415.
43. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, Mcdonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA. 2011. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298-303.
44. Rad R, Rad L, Wang W, Cadinanos J, Vassiliou G, Rice S, Campos LS, Yusa K, Banerjee R, Li MA, de la Rosa J, Strong A, Lu D, Ellis P, Conte N, Yang FT, Liu P, Bradley A. 2010. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 330:1104-1107.
45. Xu Q, Wu Z. 2000. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J. Biol. Chem. 275:36750-36757.
46. Kaneko S, Feldman RI, Yu L, Wu Z, Gritsko T, Shelley SA, Nicosia SV, Nobori T, Cheng JQ. 2002. Positive feedback regulation between Akt2 and MyoD during muscle differentiation: cloning of Akt2 promoter. J. Biol. Chem. 277:23230-23235.
47. Wilson EM, Tureckova J, Rotwein P. 2004. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol. Biol. Cell 15:497-505.
48. Magli A, Angelelli C, Ganassi M, Baruffaldi F, Matafora V, Battini R, Bachi A, Messina G, Rustighi A, Del Sal G, Ferrari S, Molinari S. 2010. Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells. J. Biol. Chem. 285: 34518-34527.